Van Gelder IC, Rienstra M, Bunting KV, et al
Zepbound (tirzepatide) is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist that is FDA-approved along with increased physical activity and a reduced-calorie diet for chronic weight management in adults with a starting body mass index (BMI) of: 30 kg/m^2 or higher (obesity) 27 kg/m^2 or higher (overweight) with at least one weight-related condition such as high cholesterol, high blood pressure (hypertension), type 2 diabetes, heart disease, or obstructive sleep apnea
Its integrated, U.S.-based, already-qualified capacity device plus fill plus container, under one roof
Take the Next Step If youre living with a chronic inflammatory condition and want to explore whether GLP-1 therapy could help, consult Dr
GLP-1 for Weight Loss Many people use GLP-1 medications for weight loss and are unsure what to do once they reach their goal weight
Izadi R, Arkan E, Jalalvand AR, Akbari V
